We are live on ! Find out more
RT

Robert Torray Torray Investment Partners

AUM $741M
1-Year Est. Return 26.16%
 

Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.

This Fund
S&P 500
This Quarter Est. Return
+11.97%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$618M
AUM Growth
+$51.1M
Cap. Flow
-$10M
Cap. Flow %
-1.62%
Top 10 Hldgs %
30.16%
Holding
97
New
3
Increased
52
Reduced
26
Closed
3

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.2M
2
AMT icon
American Tower
AMT
+$3.56M
3
RPRX icon
Royalty Pharma
RPRX
+$2.56M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.61M
5
ENB icon
Enbridge
ENB
+$875K

Top Sells

Rank Stock Value
1
GM icon
General Motors
GM
+$8.64M
2
IDXX icon
Idexx Laboratories
IDXX
+$4.23M
3
COO icon
Cooper Companies
COO
+$3.91M
4
CCI icon
Crown Castle
CCI
+$3.42M
5
TROW icon
T. Rowe Price
TROW
+$3.08M

Sector Composition

Rank Sector Weight
1 Technology 25.07%
2 Financials 20.11%
3 Healthcare 13.3%
4 Industrials 11.7%
5 Consumer Discretionary 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TROW icon
26
T. Rowe Price
TROW
$23.8B
$10.4M 1.68%
96,267
-30,946
-24% -$3.08M
SLB icon
27
SLB Ltd
SLB
$79.9B
$10.4M 1.68%
198,961
– –
AMT icon
28
American Tower
AMT
$81.9B
$9.67M 1.56%
44,808
+18,836
+73% +$3.56M
AVGO icon
29
Broadcom
AVGO
$1.75T
$9.6M 1.55%
85,980
-800
-0.9% -$75.8K
KHC icon
30
Kraft Heinz
KHC
$30.3B
$8.34M 1.35%
225,579
-43,636
-16% -$1.48M
NOW icon
31
ServiceNow
NOW
$133B
$8.1M 1.31%
57,360
-35
-0.1% -$4.41K
ADBE icon
32
Adobe
ADBE
$109B
$7.4M 1.2%
12,399
-1,210
-9% -$698K
CPRT icon
33
Copart
CPRT
$31.3B
$6.94M 1.12%
141,717
-11,227
-7% -$530K
ORLY icon
34
O'Reilly Automotive
ORLY
$72.1B
$6.69M 1.08%
105,600
+255
+0.2% +$16.1K
V icon
35
Visa
V
$693B
$6.67M 1.08%
25,631
+226
+0.9% +$55.7K
APH icon
36
Amphenol
APH
$194B
$6.12M 0.99%
123,444
+1,210
+1% +$53.5K
KLAC icon
37
KLA
KLAC
$240B
$6.01M 0.97%
103,390
-140
-0.1% -$7.29K
VRSK icon
38
Verisk Analytics
VRSK
$24.4B
$5.73M 0.93%
24,000
+298
+1% +$70.5K
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$139B
$5.72M 0.93%
+14,068
New +$5.2M
POOL icon
40
Pool Corp
POOL
$6.83B
$5.29M 0.86%
13,278
-173
-1% -$60.6K
SHW icon
41
Sherwin-Williams
SHW
$84.1B
$5.2M 0.84%
16,660
+99
+0.6% +$26.6K
ACN icon
42
Accenture
ACN
$113B
$5.03M 0.81%
14,344
+148
+1% +$47.7K
AJG icon
43
Arthur J. Gallagher & Co
AJG
$67.6B
$4.71M 0.76%
20,964
+233
+1% +$55.2K
DHR icon
44
Danaher
DHR
$154B
$4.62M 0.75%
19,958
-1,964
-9% -$418K
BX icon
45
Blackstone
BX
$108B
$4.52M 0.73%
34,495
+4,979
+17% +$539K
TYL icon
46
Tyler Technologies
TYL
$14.4B
$4.06M 0.66%
9,721
+47
+0.5% +$18.8K
AMGN icon
47
Amgen
AMGN
$238B
$3.98M 0.64%
13,831
-549
-4% -$150K
VEEV icon
48
Veeva Systems
VEEV
$40.3B
$3.69M 0.6%
19,187
+31
+0.2% +$5.84K
ENB icon
49
Enbridge
ENB
$110B
$3.63M 0.59%
100,715
+25,940
+35% +$875K
GMAB icon
50
Genmab
GMAB
$20.6B
$3.41M 0.55%
107,201
+2,685
+3% +$84.3K
1
2
3 4

Similar funds

LGA
Lebenthal Global Advisors Hauppauge, New York $741M AUM 22.36% 1-Year Est. Return
SIC
SFE Investment Counsel Los Angeles, California $742M AUM 39.38% 1-Year Est. Return
CPC
Consolidated Planning Corp Atlanta, Georgia $742M AUM 25.54% 1-Year Est. Return
NC
Northcape Capital Sydney, Australia $742M AUM 2.34% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $742M AUM 17.39% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $742M AUM 23.98% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $741M AUM 78.82% 1-Year Est. Return
TPM
Triasima Portfolio Management Montreal, Quebec, Canada $740M AUM 69.74% 1-Year Est. Return

Robert Torray's Q4 2023 Portfolio in Review

As of Q4 2023, Robert Torray held 97 positions worth $618M, up 9% from $567M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Robert Torray's Q4 2023 filing shows 3 new, 52 increased, 26 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 14,068 shares worth $5.72M. The largest sale was General Motors, an estimated $8.64M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Robert Torray's largest Q4 2023 buy was Vertex Pharmaceuticals: 14,068 shares worth $5.72M.
  • Robert Torray added most to American Tower in Q4 2023, an estimated $3.56M increase.
  • Robert Torray's biggest Q4 2023 reduction was Idexx Laboratories, cutting an estimated $4.23M.
  • Robert Torray fully exited General Motors in Q4 2023, selling an estimated $8.64M.
  • Robert Torray's ten largest holdings make up 30% of its $618M portfolio in Q4 2023.
  • Robert Torray opened 3 new positions and closed 3 in Q4 2023.
  • Robert Torray's portfolio value rose 9% quarter-over-quarter to $618M.

Based on Torray Investment Partners's 13F filing for Q4 2023, filed 8 Feb 2024.